How to Buy Theravance Biopharma Stock
Theravance Biopharma Inc
Theravance Biopharma, Inc. , a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia.
Theravance Biopharma stock last closed at $14.30, up 4.38% from the previous day, and has increased 76.33% in one year. It has overperformed other stocks in the Biotechnology industry by 1.25 percentage points. Theravance Biopharma stock is currently +81.47% from its 52-week low of $7.88, and -1.72% from its 52-week high of $14.55.
There are currently 50.36M TBPH shares outstanding. The market cap of TBPH is $720.17M. In the past 24 hours, 849,000 TBPH shares were traded.
How to Buy Theravance Biopharma Stock
Wondering how to invest in Theravance Biopharma stock? Here's how.
- Choose where to buy Theravance Biopharma stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Theravance Biopharma stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your method of payment and add your information.
- Research Theravance Biopharma stock: The Theravance Biopharma ticker symbol is TBPH. Is Theravance Biopharma stock a good investment? Should you buy shares of TBPH? How do TBPH's underlying business fundamentals look? Do top analysts think Theravance Biopharma is a good buy? Why has TBPH's stock price moved recently? (Hint: Our stock market research website can help you figure out if TBPH is a good stock to buy).
- Make your TBPH purchase: Decide if you will purchase TBPH shares at the current market price or use a limit order to buy TBPH shares at a given price.
- Get the latest scoop on your TBPH investment: Create a watchlist to the latest updates on your new investment in Theravance Biopharma shares.
Step 1: Choose where to buy Theravance Biopharma stock
You will need an online brokerage account in order to access the NASDAQ market and buy TBPH shares.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, you need to fill out some personal details so you are able to buy TBPH stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new trading account.
- Send your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on one of the best stock apps, you can securely and quickly fund your account:
Watch the video below if you need help depositing money into your new brokerage account.
Step 4: Research Theravance Biopharma stock
Once you have figured out the best place to buy Theravance Biopharma stock, it's important to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
Theravance Biopharma Numbers
Theravance Biopharma Overview
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on TBPH's stock page.
Is TBPH stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge TBPH's intrinsic value.
Using relative valuations metrics:
- TBPH may be undervalued based on its P/E ratio of 57.2x, relative to Biotechnology industry P/E ratio of -97.08x
- TBPH could be undervalued based on its P/B ratio of 3.2x, relative to Biotechnology industry P/B ratio of 4.65x
You can do additional valuation research on TBPH's stock here.
TBPH Financial Overview
Passed Health Checks:
- Total TBPH debt is lower than 5 years ago, relative to shareholder equity.
- TBPH profit margin has gone up from -73.6% to 16.9% in the past year.
- TBPH's operating cash flow of $245.02M allows it to safely service it's debt of $46.46M.
- TBPH earnings of $42.66M is not enough to cover its interest payments.
- There are more short-term assets than long-term liabilities on the TBPH balance sheet.
- There are more short-term assets than short-term liabilities on the TBPH balance sheet.
Failed Health Checks:
- TBPH has a relatively high debt to equity ratio of 0.9.
Is it a good time to buy Theravance Biopharma stock, according to analysts?
Out of 3 Wall Street analysts who give ratings on TBPH, the consensus analyst rating on TBPH is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Theravance Biopharma stock forecast page.
TBPH Trading Indicators
How are TBPH Revenues/Earnings doing?
Last year, TBPH earnings were $13.03M. During the past 2 year, TBPH's earnings have increased by -85.38% per year. This was slower than the Biotechnology industry average of 8.77%.
Last year, TBPH revenue was $77.21M. During the past 5 year, TBPH's revenue has gone up by 0.11% per year. This was slower than the Biotechnology industry average of 66.52%.
Find out more about TBPH's earnings and revenue performance here.
Who is buying/selling TBPH?
In the last 12 months, insiders at TBPH have sold more shares than they have bought.
Rhonda Farnum, SVP COMM MEDICAL AFFAIRS of TBPH, was the latest TBPH insider to sell. They sold $121,795.44 worth of TBPH stock on Aug 20, 2025.
Research more about who owns TBPH stock here.
Can I get consistent income from TBPH stock?
No, Theravance Biopharma doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your TBPH purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, use a limit order.
Hit the Open button and eToro will execute your order.
If you want more help with buying stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your TBPH investment
Now that you own some TBPH stock, you'll want to stay up-to-date on your company.
Add TBPH to a watchlist to monitor your TBPH stock.
TBPH Feed
How to Buy Stock in Theravance Biopharma
To reiterate, here are the 6 steps to buy stock in Theravance Biopharma:
- Choose where to buy Theravance Biopharma stock
- Open your brokerage account
- Deposit funds into your investment account
- Research Theravance Biopharma stock
- Make your TBPH purchase
- Get the latest scoop on your TBPH investment
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to watch your investment in Theravance Biopharma, add TBPH to your watchlist below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.